Publication | Closed Access

Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS-mutant advanced colorectal carcinoma

MedicineMulticentre Expansion CohortColorectal CancerPathologyImmune Checkpoint InhibitorPre-treated PatientsCancer TreatmentOncologyRadiation OncologyCancer ResearchColorectal Carcinoma